Streetbeat News

Products Services

BNTX

BioNTech SE and Duality Biologics announced that their antibody-drug conjugate candidate BNT323/DB-1303 received FDA Breakthrough Therapy designation for advanced endometrial cancer treatment. This designation follows promising data from a Phase 1/2 study in patients with HER2-expressing advanced endometrial cancer who had previously progressed on immune checkpoint inhibitors.

Portfolio Pulse from Benzinga Newsdesk

December 21, 2023 | 1:01 pm

HYMTF

Hyundai Motor Company plans to shut down two parts forging plants in Ulsan, South Korea, by next year as part of its strategy to transition from petrol-powered vehicles to electric vehicles (EVs). The plants, which produce engine parts, will close in January and October. Hyundai is considering outsourcing some engine components production and has started building a new 2 trillion won EV production plant in South Korea. HYMTF shares closed slightly higher at $41.50.

Portfolio Pulse from Shivani Kumaresan

December 21, 2023 | 12:56 pm

AAPL

GS

Apple Inc. (AAPL) has increased the interest rate for its Apple Card Savings Account to 4.25% APY, surpassing the industry average but still below some high-yield savings accounts like Goldman Sachs's Marcus account at 4.50% APY. The rate hike follows Apple's decision to end its financial services partnership with Goldman Sachs Group Inc. (GS), amid reports of seeking a new partner for Apple Card operations, potentially with Brazilian fintech Pismo.

Portfolio Pulse from Benzinga Neuro

December 21, 2023 | 12:54 pm

TSLA

Tesla Inc (NASDAQ:TSLA) has partnered with lending technology firm Origence to offer credit union financing to U.S. customers, aiming to make EVs more affordable by providing competitive rates and extended financing terms. This initiative allows buyers to finance their Tesla vehicles through credit unions via Origence's FI Connect, either through Tesla's website or mobile app. The move addresses concerns raised by CEO Elon Musk about high-interest rates affecting vehicle affordability.

Portfolio Pulse from Anan Ashraf

December 21, 2023 | 12:47 pm

BRNS

Barinthus Biotherapeutics is collaborating with the Coalition for Epidemic Preparedness Innovations (CEPI) and the University of Oxford to accelerate the development of the VTP-500 vaccine, aimed at preventing Middle East Respiratory Syndrome (MERS). CEPI will invest up to $34 million in funding for this initiative.

Portfolio Pulse from Benzinga Newsdesk

December 21, 2023 | 12:41 pm

DCGO

DocGo has announced a partnership to provide medical services at Enchant Milwaukee's Winter Village event. This collaboration highlights DocGo's expansion in event medical services and may positively influence the company's visibility and revenue streams.

Portfolio Pulse from Benzinga Newsdesk

December 21, 2023 | 12:40 pm

EH

EHang announced that its EH216-S passenger drone received a Standard Airworthiness Certificate from China's Civil Aviation Administration. The certified drone is set to be delivered to a customer in Guangzhou.

Portfolio Pulse from Benzinga Newsdesk

December 21, 2023 | 12:30 pm

LCID

TSLA

Lucid Group Inc (NASDAQ:LCID) CEO Peter Rawlinson announced that the company's new mid-sized EV, priced around $50,000 to compete with Tesla's Model 3 and Y, will be launched sooner than 2030. Initially stated for mid-late decade, the timeline has been misquoted as 2030. The development of this vehicle is part of Lucid's strategy to enter the high-volume family car market after its premium Air sedan and Gravity SUV. Additionally, Lucid plans to enter the UK market with right-hand drive cars, with a timeline set for late 2025.

Portfolio Pulse from Anan Ashraf

December 21, 2023 | 12:25 pm

ARTL

Artelo Biosciences has filed a U.S. patent application (number 20230404939) for solid forms of cannabidiol (CBD) and their uses. The patent application suggests that Artelo is focusing on the development of CBD-based products, which could potentially enhance their product portfolio and provide a competitive edge in the market for cannabinoid-based therapies.

Portfolio Pulse from Charles Gross

December 21, 2023 | 12:22 pm

BABA

PDD

Alibaba Group Holding Limited (NYSE:BABA) is experiencing a positive stock movement following the appointment of Eddie Wu as the head of its core Chinese e-commerce platforms, Tmall and Taobao. The change is part of Alibaba's strategy to address challenges and competition, particularly from PDD Holdings Inc (NASDAQ:PDD). Alibaba is refocusing on its cloud and e-commerce sectors, with potential sales of non-core assets ahead. Freshippo, Alibaba's supermarket chain, is adjusting its strategy to enhance price competitiveness amid a shift in China's middle-class spending habits. BABA shares were up 1.99% in premarket trading.

Portfolio Pulse from Anusuya Lahiri

December 21, 2023 | 12:21 pm